Pharming Group N.V.
PHGUF
$1.24
-$0.01-0.58%
OTC PK
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.21M | 5.33M | 4.69M | 4.69M | -14.72M |
| Total Depreciation and Amortization | 3.12M | 2.31M | 2.70M | 2.70M | 2.58M |
| Total Amortization of Deferred Charges | -- | 893.00K | -- | -- | -- |
| Total Other Non-Cash Items | 3.60M | 2.86M | 5.74M | 5.74M | 10.95M |
| Change in Net Operating Assets | 445.00K | -685.00K | -1.39M | -1.39M | 1.42M |
| Cash from Operations | 1.95M | 10.71M | 11.74M | 11.74M | 232.00K |
| Capital Expenditure | -238.00K | -269.00K | -128.00K | -128.00K | -282.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -57.48M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.52M | 224.00K | 17.08M | 17.08M | 67.45M |
| Cash from Investing | -84.76M | -45.00K | 16.96M | 16.96M | 9.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.98M | -1.37M | -1.07M | -1.07M | -715.00K |
| Issuance of Common Stock | 3.88M | 5.25M | 1.05M | 1.05M | 241.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -125.00K | -2.84M | -2.74M | -2.74M | -6.25M |
| Cash from Financing | -9.22M | 1.04M | -2.76M | -2.76M | -6.72M |
| Foreign Exchange rate Adjustments | -895.00K | 1.24M | 6.06M | 6.06M | 1.95M |
| Miscellaneous Cash Flow Adjustments | -1.00K | 0.00 | -- | -- | -- |
| Net Change in Cash | -92.93M | 12.94M | 32.00M | 32.00M | 5.15M |